ArriVent BioPharma, Inc. (AVBP)

CIK 1868279 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ArriVent BioPharma, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G/A0000315066-26-002691
Nov 2, 202640001104659-26-121410
Oct 26, 20268-K0001104659-26-118550
Oct 19, 20268-K0001104659-26-116736
Oct 13, 2026SCHEDULE 13G0001213900-26-109019
Oct 13, 20268-K0001104659-26-115161
Oct 8, 2026SCHEDULE 13D/A0000947871-26-000931
Oct 6, 20268-K0001104659-26-113898
Aug 12, 20268-K0001104659-26-094869
Aug 12, 202610-Q0001104659-26-094902
Jul 27, 2026SCHEDULE 13G/A0002012383-26-002185
Jun 22, 202640001104659-26-076566
Jun 22, 20268-K0001104659-26-076352
Jun 22, 202640001104659-26-076567
Jun 22, 202640001104659-26-076569
Jun 22, 202640001104659-26-076570
May 11, 20268-K0001104659-26-058706
May 11, 20268-K0001104659-26-058638
May 11, 202610-Q0001104659-26-058650
May 11, 2026424B50001104659-26-058700
May 6, 2026SCHEDULE 13G/A0000315066-26-001106
Apr 28, 2026ARS0001104659-26-050350
Apr 28, 2026DEFA14A0001104659-26-050344
Apr 28, 2026DEF 14A0001104659-26-050337
Mar 17, 20268-K0001104659-26-029588